Related Experiment Videos
Intraventricular malignant triton tumour
1Department of Neurosurgery, Kurume University School of Medicine, Fukuoka, Japan.
Acta Neurochirurgica
|July 7, 2000
Summary
This study reports the first intraventricular malignant triton tumour (MTT) in a patient with neurofibromatosis type 1. Aggressive treatment with surgery and radiochemotherapy is recommended for this rare central nervous system tumor.
Area of Science:
- Neuro-oncology
- Pathology
- Neurosurgery
Background:
- Neurofibromatosis type 1 (NF1) is a genetic disorder associated with an increased risk of various tumors.
- Malignant triton tumours (MTTs) are rare neoplasms typically found in the paraspinal region, comprising rhabdomyosarcomatous differentiation in a malignant peripheral nerve sheath tumor.
- Intraventricular tumors are uncommon, and MTTs within the central nervous system are exceedingly rare.
Observation:
- A 57-year-old male with neurofibromatosis type 1 presented with cognitive decline.
- Neuroimaging revealed an enhancing lesion within the left lateral ventricle.
- Surgical resection was performed via a parieto-occipital transcallosal approach.
Findings:
- Operative findings suggested the tumor originated from perivascular nerves.
- Pathological diagnosis confirmed a malignant triton tumour (MTT).
- This represents the first documented case of an intraventricular MTT.
Implications:
- The case highlights the potential for MTTs to occur in unusual locations within the central nervous system.
- Aggressive multimodal treatment, including radical surgery and adjuvant radiochemotherapy, is crucial for managing intraventricular MTTs.
- This finding expands the understanding of tumor diversity in neurofibromatosis type 1.